Meribank Biotech Co., Ltd (4724.TWO)

TWD 28.55

(-1.89%)

Annual Income Statements

(In TWD)
Breakdown 2023 2022 2021 2020 2019
Revenue 234.34 Million 180.12 Million 163.07 Million 194.39 Million 160.95 Million
Cost of Revenue 95.47 Million 85.35 Million 73.02 Million 79.24 Million 67.91 Million
Gross Profit 138.87 Million 94.77 Million 90.05 Million 115.14 Million 93.03 Million
Operating Expenses 138.87 Million 205.14 Million 181.99 Million 181.1 Million 153.67 Million
Selling, General and Administrative Expenses 221.9 Million 179.2 Million 165.87 Million 174.67 Million 145.57 Million
Research and Development Expenses 35.48 Million 25.94 Million 16.11 Million 6.42 Million 4.87 Million
Other Expenses - 11.69 Million 3.18 Million 16.76 Million -
Cost and Expenses 352.85 Million 290.49 Million 255.01 Million 260.35 Million 221.59 Million
Operating Income -123.15 Million -102.83 Million -92.78 Million -49.57 Million -57.41 Million
Interest Expense 847 Thousand 985 Thousand 1.12 Million 742 Thousand 554 Thousand
Income Tax Expense -441 Thousand -81 Thousand - - -
Earnings before Tax -129.94 Million -103.22 Million -99.19 Million -54.45 Million -59.89 Million
Net Income -125.34 Million -102.13 Million -99.19 Million -54.45 Million -59.89 Million
Earnings Per Share Basic -1.99 -1.62 -1.63 -1.02 -1.13
Earnings Per Share Diluted -1.99 -1.62 -1.63 -1.02 -1.13
Weighted Average Shares Outstanding 62.84 Million 63.17 Million 60.98 Million 53.3 Million 52.97 Million
Weighted Average Shares Outstanding (Diluted) 62.84 Million 63.17 Million 60.98 Million 53.3 Million 52.97 Million
Gross Margin 0.59 0.53 0.55 0.59 0.58
EBIT Margin -0.39 -0.39 -0.39 -0.13 -0.28
Profit Margin -0.53 -0.57 -0.61 -0.28 -0.37
EBITDA -92.56 Million -70.07 Million -68.59 Million -29.94 Million -38.58 Million
Earnings Before Tax Margin -0.53 -0.57 -0.57 -0.26 -0.36

Income Statement Charts